These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 25689117)

  • 1. Montanide ISA 71 VG is Advantageous to Freund's Adjuvant in Immunization Against S. aureus Infection of Mice.
    Klimka A; Michels L; Glowalla E; Tosetti B; Krönke M; Krut O
    Scand J Immunol; 2015 May; 81(5):291-7. PubMed ID: 25689117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B--a prerequisite for clinical development.
    Huijbers EJ; Femel J; Andersson K; Björkelund H; Hellman L; Olsson AK
    Vaccine; 2012 Jan; 30(2):225-30. PubMed ID: 22079080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of the Plasmodium falciparum Pf332-DBL domain in combination with different adjuvants.
    Du C; Nilsson S; Lu H; Yin J; Jiang N; Wahlgren M; Chen Q
    Vaccine; 2010 Jul; 28(31):4977-83. PubMed ID: 20653104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) along with incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom.
    Waghmare A; Deopurkar RL; Salvi N; Khadilkar M; Kalolikar M; Gade SK
    Vaccine; 2009 Feb; 27(7):1067-72. PubMed ID: 19100805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potent biodegradable adjuvants that efficiently break self-tolerance--a key issue in the development of therapeutic vaccines.
    Ringvall M; Huijbers EJ; Ahooghalandari P; Alekseeva L; Andronova T; Olsson AK; Hellman L
    Vaccine; 2009 Dec; 28(1):48-52. PubMed ID: 19835827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine.
    Kumar S; Jones TR; Oakley MS; Zheng H; Kuppusamy SP; Taye A; Krieg AM; Stowers AW; Kaslow DC; Hoffman SL
    Infect Immun; 2004 Feb; 72(2):949-57. PubMed ID: 14742540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoenhancing effects of Montanide ISA oil-based adjuvants on recombinant coccidia antigen vaccination against Eimeria acervulina infection.
    Jang SI; Lillehoj HS; Lee SH; Lee KW; Park MS; Bauchan GR; Lillehoj EP; Bertrand F; Dupuis L; Deville S
    Vet Parasitol; 2010 Sep; 172(3-4):221-8. PubMed ID: 20541870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of ligand-binding domain of fibronectin-binding protein on mastitis induced by Staphylococcus aureus in mice.
    Hu C; Gong R; Guo A; Chen H
    Vaccine; 2010 May; 28(24):4038-44. PubMed ID: 20416265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montanide IMS 1313 N VG PR nanoparticle adjuvant enhances antigen-specific immune responses to profilin following mucosal vaccination against Eimeria acervulina.
    Jang SI; Lillehoj HS; Lee SH; Lee KW; Lillehoj EP; Bertrand F; Dupuis L; Deville S
    Vet Parasitol; 2011 Dec; 182(2-4):163-70. PubMed ID: 21700391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory activity of novel adjuvant formulations based on Montanide ISA oil-based adjuvants and peptidoglycan monomer.
    Habjanec L; Halassy B; Tomasić J
    Int Immunopharmacol; 2008 May; 8(5):717-24. PubMed ID: 18387514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of HBsAg in Montanide ISA 51VG adjuvant: Immunogenicity study and monitoring long-lived humoral immune responses.
    Savoji MA; Sereshgi MMA; Ghahari SMM; Asgarhalvaei F; Mahdavi M
    Int Immunopharmacol; 2021 Jul; 96():107599. PubMed ID: 33848910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of several adjuvant emulsion regimens for the production of polyclonal antisera in rabbits.
    Johnston BA; Eisen H; Fry D
    Lab Anim Sci; 1991 Jan; 41(1):15-21. PubMed ID: 1849580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montanide™ ISA 71 VG adjuvant enhances antibody and cell-mediated immune responses to profilin subunit antigen vaccination and promotes protection against Eimeria acervulina and Eimeria tenella.
    Jang SI; Lillehoj HS; Lee SH; Lee KW; Lillehoj EP; Bertrand F; Dupuis L; Deville S
    Exp Parasitol; 2011 Jan; 127(1):178-83. PubMed ID: 20728439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines.
    Osorio Y; Cohen J; Ghiasi H
    Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):506-14. PubMed ID: 14744892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with Clostridium perfringens recombinant proteins in combination with Montanide™ ISA 71 VG adjuvant increases protection against experimental necrotic enteritis in commercial broiler chickens.
    Jang SI; Lillehoj HS; Lee SH; Lee KW; Lillehoj EP; Hong YH; An DJ; Jeong W; Chun JE; Bertrand F; Dupuis L; Deville S; Arous JB
    Vaccine; 2012 Aug; 30(36):5401-6. PubMed ID: 22713719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) formulated in oil-based Montanides.
    Hirunpetcharat C; Wipasa J; Sakkhachornphop S; Nitkumhan T; Zheng YZ; Pichyangkul S; Krieg AM; Walsh DS; Heppner DG; Good MF
    Vaccine; 2003 Jun; 21(21-22):2923-32. PubMed ID: 12798636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses and side effects of five different oil-based adjuvants in mice.
    Leenaars M; Koedam MA; Hendriksen CF; Claassen E
    Vet Immunol Immunopathol; 1998 Feb; 61(2-4):291-304. PubMed ID: 9613442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants.
    Qiu Q; Wang RY; Jiao X; Jin B; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Vaccine; 2008 Oct; 26(43):5527-5534. PubMed ID: 18675871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incomplete Freund's adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment.
    Pollack KE; Meneveau MO; Melssen MM; Lynch KT; Koeppel AF; Young SJ; Turner S; Kumar P; Sol-Church K; Mauldin IS; Slingluff CL
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32350119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of novel PGM-containing incomplete Seppic adjuvants in rabbits.
    Halassy B; Vdović V; Habjanec L; Balija ML; Gebauer B; Sabioncello A; Santek T; Tomasić J
    Vaccine; 2007 Apr; 25(17):3475-81. PubMed ID: 17239503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.